- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2731-6998
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction: Ethics approval and consent to participate ; volume:5 ; number:1 ; day:30 ; month:1 ; year:2023 ; pages:1-2 ; date:12.2023
Collagen and leather ; 5, Heft 1 (30.1.2023), 1-2, 12.2023
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42825-023-00111-z
- URN
-
urn:nbn:de:101:1-2023042511383528859083
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2025, 13:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ethics Review Committee approval and informed consent: an analysis of biomedical publications originating from Sri Lanka
Natural ethics and informed consent
Natural ethics and informed consent
Correction: Eplontersen: First Approval
Correction: Zilucoplan: First Approval
Correction: Elacestrant: First Approval
Correction: Vorasidenib: First Approval
Correction to: Lonafarnib: First Approval
Correction to: Pexidartinib: First Approval
Correction to: Nedosiran: First Approval
Correction to: Lenacapavir: First Approval
Correction to: Zavegepant: First Approval
Ethics Review Committee approval and informed consent: an analysis of biomedical publications originating from Sri Lanka
Natural ethics and informed consent
Natural ethics and informed consent
Correction: Eplontersen: First Approval
Correction: Zilucoplan: First Approval
Correction: Elacestrant: First Approval
Correction: Vorasidenib: First Approval
Correction to: Lonafarnib: First Approval
Correction to: Pexidartinib: First Approval
Correction to: Nedosiran: First Approval
Correction to: Lenacapavir: First Approval
Correction to: Zavegepant: First Approval
Ethics Review Committee approval and informed consent: an analysis of biomedical publications originating from Sri Lanka
Natural ethics and informed consent
Natural ethics and informed consent
Correction: Eplontersen: First Approval
Correction: Zilucoplan: First Approval
Correction: Elacestrant: First Approval
Correction: Vorasidenib: First Approval
Correction to: Lonafarnib: First Approval
Correction to: Pexidartinib: First Approval
Correction to: Nedosiran: First Approval
Correction to: Lenacapavir: First Approval